ResMed enters accelerated share repurchase agreement for $450 million stock
ResMed (NYSE:RMD) entered an accelerated share repurchase agreement to repurchase $450 million of common stock, per an SEC filing.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.